Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenoxodiol + Carboplatin in Platinum-Resistant Ovarian Cancer
NCT00382811Phase 3Completed
- Sponsor
- MEI Pharma
- Start
- Oct 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of idronoxil in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by MEI Pharma. Started Oct 2006; status: completed.
02
Drugs
idronoxil
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00382811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382811.